Results 171 to 180 of about 42,175 (206)

Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease

Endocrine Reviews, 2023
Daniel J Drucker
exaly  

Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.

Best practice & research. Clinical endocrinology & metabolism, 2005
The glucagon-like peptides (glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2)) are released from enteroendocrine cells in response to nutrient ingestion. GLP-1 enhances glucose-stimulated insulin secretion and inhibits glucagon secretion, gastric emptying and feeding. GLP-1 also has proliferative, neogenic and antiapoptotic effects on
Laurie L, Baggio, Daniel J, Drucker
openaire   +1 more source

Glucagon and Glucagon-like Peptides

2004
Daniel M. Kemp, Joel F. Habener
openaire   +1 more source

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

New England Journal of Medicine, 1992
Bo Ahrén
exaly  

Glucagon-like Peptide-1

2006
  +4 more sources

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Lancet, The, 2002
Sten Madsbad, Jens J Holst Dmsci
exaly  

A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity

Circulation, 2013
Ilya M Mukovozov, Ren-Ke Li, Filio Billia   +2 more
exaly  

Glucagon-like peptide-2

2021
openaire   +1 more source

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

Lancet, The, 2014
Caroline K Kramer, Bernard Zinman Cm, Ravi Retnakaran   +2 more
exaly  

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

Nature Medicine, 2003
Matthew J During, Helen L Fitzsimons, Matthias Klugmann   +2 more
exaly